tDCS for Depression: Evidence, How It Works & What to Expect

If you're living with depression and medication isn't working well enough, or comes with side effects you'd rather avoid, transcranial direct current stimulation (tDCS) may be worth exploring. It's a non-invasive brain stimulation treatment that targets the specific brain region most involved in depression.

This page explains how tDCS treats depression, what the clinical evidence shows, and what a typical treatment course looks like. You'll find concrete numbers from published studies, a realistic timeline for improvement, and guidance on who benefits most.

---

Why tDCS for depression?

Depression is one of the most common mental health conditions worldwide. And despite effective treatments existing, a significant number of people struggle to find relief.

Fewer than half of people with depression improve substantially on their first antidepressant medication, and only about one in three achieve full remission (Rush et al., 2006). That leaves a significant number of people still searching for relief — whether through medication changes, combination approaches, or alternative treatments.

tDCS offers a different approach. Instead of affecting brain chemistry through the bloodstream, it directly targets the brain areas most involved in mood regulation: the left dorsolateral prefrontal cortex (left DLPFC). This region is consistently underactive in people with depression.

The treatment is non-invasive, has minimal side effects, and can be used at home with a medical-grade device like Sooma tDCS™. It's moving from a research tool to a mainstream treatment option, supported by large clinical trials and real-world data from over 150 clinics worldwide.

---

How tDCS treats depression

To understand why tDCS works for depression, it helps to understand what's happening in the brain.

The left DLPFC problem

In people with depression, the left dorsolateral prefrontal cortex (left DLPFC) is typically underactive. This brain region plays a central role in mood regulation, motivation, decision-making, and emotional processing. When it's not functioning properly, the symptoms of depression emerge.

At the same time, there's often an imbalance between the left and right prefrontal cortex. The right side, associated with negative emotions and withdrawal, may be relatively overactive.

What tDCS does

tDCS delivers a gentle, constant electrical current through two soft electrodes positioned on the head. For depression treatment, the positive electrode is placed over the left DLPFC. This gently increases activity in this underactive region.

The negative electrode is placed over the right DLPFC — the matching region on the opposite side of your forehead. This gently reduces activity on that side, helping restore balance between the two hemispheres.

Think of it as turning up the volume on a speaker that's been too quiet, while turning down the one that's been too loud.

Why repeated sessions matter

A single session of tDCS has temporary effects. But repeated sessions trigger neuroplasticity - the brain's ability to rewire itself. Over several weeks of regular treatment, the brain gradually shifts toward healthier patterns of activity. These changes can persist long after treatment ends.

This is similar to physical exercise. One workout doesn't transform your fitness, but consistent training over weeks produces lasting change.

---

The evidence

tDCS for depression is backed by multiple large clinical trials. Here are the key findings.

Large-scale clinical trials

Woodham et al. (2025) — Nature Medicine This randomized controlled trial studied 174 patients using tDCS at home for depression. Results showed that 57.5% of patients achieved remission - meaning their symptoms reduced to minimal or none. This is the largest home-based tDCS trial for depression to date.

Lõokene et al. (2022) — Real-World Data A study of 410 patients treated in real-world clinical settings found a 55% response rate — meaning more than half of patients saw significant improvement. Notably, this population included many patients with complex conditions who were already taking multiple psychotropic medications, making this a conservative real-world benchmark. Among patients with simpler medication profiles or no medication, response rates were higher still.

SELECT-TDCS Trial — Brunoni et al. (2013), JAMA Psychiatry This landmark study of 120 patients compared tDCS head-to-head with sertraline (Zoloft), one of the most commonly prescribed antidepressant medications. The result: tDCS produced antidepressant effects comparable to sertraline. Combining the two treatments produced significantly better outcomes than either alone. This was the first large trial to directly compare tDCS to a standard antidepressant medication.

Long-term outcomes

One of the most important questions about any depression treatment is whether it lasts. Follow-up data from published tDCS studies are encouraging:

A 6-month follow-up of UK participants from the home-based trial found a 76% clinical response rate among those who completed the assessment (Woodham et al., 2025). Notably, among those who had already achieved a response by the end of the open-label phase, 90% sustained that response at the 6-month mark. During follow-up, participants were free to continue using the tDCS device as needed: roughly two-thirds chose to do so — most at about twice per week — while one-third did not continue.

A separate study focused on maintenance after an acute response (Aparicio et al., 2019). Responders — including a higher proportion of difficult-to-treat patients — received twice-weekly sessions over 24 weeks. Overall, 73.5% remained relapse-free by the end of follow-up, and among patients who were not treatment-resistant, 92.3% maintained their response.

Context — antidepressant discontinuation: To put these figures in perspective, large meta-analyses of patients who switch from active medication to placebo (discontinuation) report relapse rates of roughly 35–45% over one year — specifically 39.7% in a pool of 40 studies (Kato et al., 2021). While different study designs prevent a direct head-to-head comparison, these figures highlight the clinical importance of finding durable, non-pharmacological maintenance options.

Safety profile

Across more than 33,000 treatment sessions, no serious adverse events have been reported. The most common side effects are mild and temporary: tingling under the electrodes and slight skin redness. Unlike many antidepressant medications, tDCS does not cause weight gain, sexual dysfunction, or withdrawal symptoms.

Based on this body of evidence, tDCS has received an A-level evidence recommendation for the treatment of depression.

---

Treatment course for depression

Standard treatment setup

A typical home-based program with Sooma tDCS™ follows two phases that mirror how tDCS builds effect over time: an intensive start, then a structured maintenance rhythm.

• Electrode placement: Positive electrode over the left DLPFC (mood regulation area), negative electrode over the right DLPFC (the corresponding area on the opposite side).
• Session duration: 30 minutes per session.

Weeks 1-3 (intensive phase): Five guided sessions per week help establish a consistent stimulation schedule. The Sooma App shows electrode placement using the ComfoCap headcap, times each session, and logs your progress—so you follow a clear protocol without guessing placement or dose.

From week 4 onward (maintenance phase): Three sessions per week are used to maintain and build on gains. Smart reminders in the app help you stay on schedule while fitting therapy into your week.

You continue at three sessions per week until you reach your plan total. The device stays with you; you can order continuation treatments at any time to keep going with the same device.

In research, a 6-month UK follow-up after the Woodham home-based trial reported a 76% clinical response rate and 90% of prior open-label responders still meeting response criteria (Woodham et al., 2025). A separate small study of twice-weekly maintenance over 24 weeks reported ~74% relapse-free survival overall (Aparicio et al., 2019).

Combining with other treatments

Because tDCS works locally on the brain rather than through the bloodstream, it produces no systemic side effects and carries no risk of drug-drug interactions. That makes it straightforward to add on top of an existing treatment plan, regardless of what other medications a person is taking.

This matters particularly for groups like older adults or people managing chronic illnesses, who often take several medications at the same time (cardiovascular, metabolic, pain). Adding an antidepressant to that mix can be difficult because of interaction risks and compounding side effects. tDCS sidesteps these concerns entirely, offering an effective depression treatment that doesn't complicate the rest of someone's medication regimen.

• With antidepressant medication: tDCS can be used safely alongside SSRIs and other antidepressants. Evidence from the SELECT-TDCS trial suggests the combination may enhance effects compared to either treatment alone.
• With psychotherapy: tDCS can be combined with cognitive behavioral therapy (CBT) or other forms of talk therapy. Some clinicians recommend doing therapy sessions shortly after tDCS, when the brain may be more receptive to learning new thought patterns.
• With other medications: Because there are no systemic interactions, tDCS can be used alongside medications for other conditions — a key advantage for anyone managing multiple prescriptions.

This flexibility makes tDCS valuable whether you're adding it to an existing treatment plan or exploring it as a standalone option.

---

Who benefits most

tDCS for depression has been studied across several patient groups. Based on the evidence, people who may be especially well-suited include:

People with major depressive disorder who want a non-pharmaceutical option. tDCS is indicated for depression and works through gentle brain stimulation rather than medication. If you prefer to avoid or limit drugs, tDCS is an evidence-based option to discuss with your doctor.

People who can't tolerate medication side effects. Antidepressant medications can cause weight gain, sexual dysfunction, fatigue, and other systemic side effects. Because tDCS targets the brain directly rather than working through the bloodstream, it avoids these issues. The most common side effects are mild tingling and temporary skin redness.

People seeking a standalone treatment. The SELECT-TDCS trial (Brunoni et al. (2013), JAMA Psychiatry, 120 patients) compared tDCS directly with sertraline and found tDCS alone produced antidepressant effects comparable to the medication. Real-world data supports this: Lõokene et al. (2022) followed 410 patients in everyday clinical practice and found an overall 55% response rate. Among patients who were not managing complex psychiatric conditions or taking multiple medications, the response rate reached 68%, while the lower overall figure reflects the inclusion of more challenging cases.

People who want depression treatment at home. If regular clinic visits are hard to fit into your life, home-based tDCS with a medical-grade device lets you follow a structured protocol on your schedule while still checking in with your healthcare provider as needed.

---

What to expect: a realistic timeline

Understanding the timeline helps set realistic expectations. Depression didn't develop overnight, and improvement from tDCS is cumulative and gradual—often becoming clearer after the first few weeks of regular sessions.

Weeks 1-3: building the foundation

During the intensive phase (five sessions per week), many people notice little or no change in mood at first. This is completely normal. The brain needs repeated stimulation to shift activity patterns; early sessions lay the groundwork for later improvement. Don't be discouraged if you feel the same as before.

What you are likely to notice at this stage is mild tingling or warmth under the electrodes during each session; this usually fades quickly afterward.

Weeks 3-4: early signs of improvement

As you transition to three sessions per week, cumulative effects often become easier to detect. Common early improvements include:

• Better sleep quality
• More energy during the day
• Finding it a bit easier to concentrate
• Moments of improved mood

These changes are often subtle. Family members or close friends may notice them before you do.

Weeks 4-6: clearer improvements appear

By roughly weeks 4-6, many patients notice clearer improvements from tDCS. Patients who respond during this period typically report:

• Noticeably improved mood and outlook
• Better ability to engage in daily activities
• Improved motivation and interest in things they used to enjoy
• More stable emotions throughout the day

If you haven't felt a clear change yet, that's okay. Everyone's brain responds at its own pace. Benefits from tDCS are cumulative — they continue to build with ongoing sessions. Some people notice meaningful improvement in weeks 6-8 or later. The 6-month treatment program is designed to give your brain the time it needs.

Ongoing: maintenance

Continuing at three sessions per week until you complete your plan in total helps sustain improvement and limit relapse. Your package is designed to support this at home: the device remains yours, and you can order continuation treatments whenever you need to extend your program. We recommend discussing any change in symptoms or treatment plan with your doctor.

---

tDCS vs other depression treatments

Treatment	How it works	Setting	Typical duration	Common side effects	Approximate cost
tDCS (Sooma Depression Therapy)	Gentle brain stimulation targeting mood regulation area (left DLPFC)	Home (after setup)	30 min/session; wks 1-3: 5×/wk, then 3×/wk	Mild tingling, skin redness, transient headache	599€
Antidepressant medication (SSRIs)	Adjust serotonin levels throughout the body	Home (daily pill)	Ongoing (months to years)	Weight gain, sexual dysfunction, fatigue, withdrawal	€10-50/month
TMS	Magnetic pulses targeting mood regulation area (left DLPFC)	Clinic only	20-40 min, 5x/week, 4-6 weeks	Headache, scalp discomfort, muscle spasms	€3,000-8,000/course
ECT	Controlled electrical currents under anesthesia	Hospital	3x/week, 3-4 weeks	Memory issues, confusion, anesthesia risks	€5,000+/course
Psychotherapy (CBT)	Restructures thought patterns	Clinic or online	50 min/week, 12-20 weeks	None (physical)	€50-150/session

---

Take the next step

If you're living with depression and looking for an effective, evidence-based treatment with minimal side effects, tDCS may be right for you. Talk to your doctor about whether Sooma Depression Therapy could be a good fit for your situation.

Explore Sooma tDCS →

See how tDCS works →

For healthcare professionals →

This page is for informational purposes only and does not constitute medical advice. Sooma tDCS™ is a CE Class IIa medical device. We recommend consulting your doctor before beginning any new treatment or making changes to your treatment plan.

Last updated: March 2026